These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 3885981

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J, Cody RJ, Laragh JH.
    Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
    Faxon DP, Halperin JL, Creager MA, Gavras H, Schick EC, Ryan TJ.
    Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
    [Abstract] [Full Text] [Related]

  • 4. Hemodynamic and regional blood flow response to captopril in congestive heart failure.
    Levine TB, Olivari MT, Cohn JN.
    Am J Med; 1984 May 31; 76(5B):38-42. PubMed ID: 6375361
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failure.
    Packer M, Lee WH, Medina N, Yushak M.
    J Am Coll Cardiol; 1985 Sep 31; 6(3):635-45. PubMed ID: 2993397
    [Abstract] [Full Text] [Related]

  • 7. Improvement of chronic congestive heart-failure by oral captopril.
    Turini GA, Brunner HR, Gribic M, Waeber B, Gavras H.
    Lancet; 1979 Jun 09; 1(8128):1213-5. PubMed ID: 87679
    [Abstract] [Full Text] [Related]

  • 8. Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure.
    Silberbauer K, Punzengruber C, Sinzinger H.
    Cardiology; 1983 Jun 09; 70(6):297-307. PubMed ID: 6370431
    [Abstract] [Full Text] [Related]

  • 9. A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response.
    Chatterjee K, Parmley WW, Cohn JN, Levine TB, Awan NA, Mason DT, Faxon DP, Creager M, Gavras HP, Fouad FM.
    Am Heart J; 1985 Aug 09; 110(2):439-47. PubMed ID: 3895877
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders.
    Packer M, Medina N, Yushak M.
    Am J Cardiol; 1984 Oct 01; 54(7):771-7. PubMed ID: 6091434
    [Abstract] [Full Text] [Related]

  • 11. Effect of angiotensin converting enzyme inhibition on plasma endothelin in congestive heart failure.
    Townend J, Doran J, Jones S, Davies M.
    Int J Cardiol; 1994 Mar 01; 43(3):299-304. PubMed ID: 8181887
    [Abstract] [Full Text] [Related]

  • 12. Hemodynamic effects of captopril in patients with severe chronic heart failure.
    LeJemtel TH, Keung E, Frishman WH, Ribner HS, Sonnenblick EH.
    Am J Cardiol; 1982 Apr 21; 49(6):1484-8. PubMed ID: 7041587
    [Abstract] [Full Text] [Related]

  • 13. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
    Faxon DP, Creager MA, Halperin JL, Bernard DB, Ryan TJ.
    Am J Med; 1984 May 31; 76(5B):104-10. PubMed ID: 6203405
    [Abstract] [Full Text] [Related]

  • 14. Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
    Wenting GJ, Man in't veld AJ, Woittiez AJ, Boomsma F, Laird-Meeter K, Simoons ML, Hugenholtz PG, Schalekamp MA.
    Br Heart J; 1983 Jan 31; 49(1):65-76. PubMed ID: 6336940
    [Abstract] [Full Text] [Related]

  • 15. Hemodynamic and radionuclide effects of acute captopril therapy for heart failure: changes in left and right ventricular volumes and function at rest and during exercise.
    Massie B, Kramer BL, Topic N, Henderson SG.
    Circulation; 1982 Jun 31; 65(7):1374-81. PubMed ID: 6280890
    [Abstract] [Full Text] [Related]

  • 16. Effects of captopril on forearm oxygen consumption during dynamic handgrip exercise in patients with congestive heart failure.
    Imaizumi T, Takeshita A, Nakamura N, Sakai K, Hirooka Y, Suzuki S, Yoshida M, Nakamura M.
    Jpn Heart J; 1990 Nov 31; 31(6):817-28. PubMed ID: 2084278
    [Abstract] [Full Text] [Related]

  • 17. Effects of captopril in heart failure complicating acute myocardial infarction and persistence of acute haemodynamic effects in chronic heart failure after 3 years of treatment.
    Mattioli G, Ricci S, Rigo R, Fusaro MT, Cappello C.
    Postgrad Med J; 1986 Nov 31; 62 Suppl 1():164-6. PubMed ID: 3534855
    [Abstract] [Full Text] [Related]

  • 18. Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.
    Levine TB, Franciosa JA, Cohn JN.
    Circulation; 1980 Jul 31; 62(1):35-41. PubMed ID: 6247102
    [No Abstract] [Full Text] [Related]

  • 19. Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure.
    Creager MA, Halperin JL, Bernard DB, Faxon DP, Melidossian CD, Gavras H, Ryan TJ.
    Circulation; 1981 Sep 31; 64(3):483-9. PubMed ID: 6266691
    [Abstract] [Full Text] [Related]

  • 20. The renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure. Effect of angiotensin I converting enzyme inhibitor SQ 14225 (Captopril).
    Kubo S, Nishioka A, Nishimura H, Sonotani N, Takatsu T.
    Jpn Circ J; 1980 Jun 31; 44(6):427-37. PubMed ID: 6995635
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.